Genmab — Maj 2015
-
Syntes heller ikke fremtidsudsigtene er gode for Arzerra sukker. Men omvendt tjener vi jo stadig 100-150 mio. kr. i royalty pt. så det er jo også at tage med
-
BTW GSK har Q1 i morgen, så får vi salgtal for januar og februar hvor de solgte arzerra inden overdragelsen.
-
-
Carnegie er med. Siger at Jannsen har tromlet alle konkurrenterne ned fordi de har rekruteret så hurtit
-
de andre kan simpelthen ikke få sites at køre studier hos

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind